Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nexalin Technology Inc (NXL)

Nexalin Technology Inc (NXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nexalin Technology, Inc. Announces Validation of DIFS Technology in Peer-Reviewed Editorial on Psychiatric Treatment Quiver Quantitative, Inc. - Tue Nov 26, 7:12PM CST

Nexalin's DIFS technology gains validation in Psychotherapy and Psychosomatics, highlighting its potential for treating psychiatric disorders non-invasively.Quiver AI SummaryNexalin Technology, Inc. has...

NXL : 2.63 (-14.05%)
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market GlobeNewswire - Tue Nov 26, 9:00AM CST

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology CEO Provides Letter to Shareholders GlobeNewswire - Mon Nov 11, 7:00AM CST

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th GlobeNewswire - Fri Nov 1, 1:00PM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements GlobeNewswire - Fri Nov 1, 9:34AM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease GlobeNewswire - Mon Oct 28, 7:30AM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA GlobeNewswire - Tue Oct 22, 1:15PM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients GlobeNewswire - Thu Oct 17, 7:30AM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs GlobeNewswire - Mon Oct 14, 7:30AM CDT

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot